OSBORNE DAVID W 5
5 · Arcutis Biotherapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
OSBORNE DAVID W
Chief Technical Officer
Transactions
- Gift
Common Stock
2020-12-18−12,500→ 238,033 total
Holdings
- 0(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- [F2]Since it has been determined that the Reporting Person does not have voting or investment power over the (i) 62,478 shares held by The Osborne Irrevocable Trust FBO John Osborne and (ii) 62,478 shares held by The Osborne Irrevocable Trust FBO Sharon Osborne (together, the "Trusts"), is not the Trustee of said Trusts, and therefore is not deemed to beneficially own the Trust Shares, the Trust Shares will be excluded from the Reporting Person's future Section 16 reports.